Skip to main content
. 2015 Dec 12;8(6):474–479. doi: 10.1016/j.tranon.2015.11.002

Figure 1.

Figure 1

(A) Progression-free survival according to the UGT1A1 genotype (P = .002); 6/6, 6/7, and 7/7 means *1/*1, *1/*28, and *28/*28 genotype, respectively. (B) Overall survival in mCRC patients with or without metastasectomy (P = .015).